News and Breakthroughs
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news. Visit our Photo Gallery to view photos and videos from various events
TG2, an enzyme known to help cancers spread more quickly, also plays a role in regulating T-cells — opening the door to dual inhibition, according to a recent Northwestern Medicine study.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has received a Merit Extension Award from the National Cancer Institute, one of only two Comprehensive Cancer Centers in the nation to earn the recognition.
From teasing out determinants of health disparities to developing precision medicine treatments, clinicians and scientists from the Lurie Cancer Center are dramatically changing the landscape for all men with prostate cancer.
The underexpression of a specific metabolic enzyme metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma, which accounts for 80 percent of all kidney cancers, according to a recent study.
In this newly created role, Platanias will oversee all cancer-related activities at Northwestern, and will retain his current role as director of the Lurie Cancer Center.
A new generation of philanthropic leadership will support the mission and goals of the Lurie Cancer Center.
Tisagenlecleucel, a chimeric antigen receptor (CAR) T-cell immunotherapy, demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia, according to recent findings.
Important Questions Answered by Our Scientists. On October 13, Lurie Cancer center held a virtual Town Hall meeting on COVID-19 Vaccines, Boosters, Variants and Cancer.
An especially deadly subtype of T-cell lymphoma is distinguished by unique mutations in the JAK-STAT pathway, according to a recent Northwestern Medicine study.
Northwestern scientists are testing novel approaches to break the grip of glioblastoma
Northwestern’s Brain Tumor SPORE — part of the Lurie Cancer Center — is now three years old, and the bench to bedside process is producing results.
Blocking an inhibitory pathway within a subset of specialized T-cells may improve overall immune response against virally driven cancers, according to findings published in Nature.
Many cancers produce an enzyme called IDO that suppresses immune system activity, but the long-held hypothesis of how this mechanism operates requires revision, according to a Northwestern Medicine study.
Anthony Yang, MD, has received an Outstanding Performance Award from the Commission on Cancer’s (CoC) Cancer Liaison Program for his contributions as the physician quality leader of the Lurie Cancer Center at Northwestern Memorial Hospital. He is one of just ten Cancer Liaison Physicians (CLP) in the nation selected to receive this new award.
Harmful side effects from a common chemotherapy drug could be prevented in patients with a specific mutation by targeting retinoic acid receptors, according to a recent study.
Circulating tumor cells use the surface protein ICAM1 to strengthen stem cell programs and facilitate formation of tumor cell clusters, which can travel from primary tumors to other organs in the body.
- Mulcahy and Salem Spearhead First Trial to Demonstrate Benefits of Radioembolization in Patients with Colorectal Liver Metastases09.21.2021
An international, multicenter, open-label trial, spearheaded by Lurie Cancer Center members and global Co-Principal Investigators, Mary Mulcahy, MD, and Riad Salem, MD, is the first randomized controlled clinical trial to demonstrate the benefits of radioembolization in patients with colorectal liver metastases, according to findings published in the Journal of Clinical Oncology.
Northwestern Medicine physician-scientist Amy Heimberger, MD, has been named by President Biden to the National Cancer Advisory Board, which plays an important role in setting the course for the nation's cancer research programs.
Ankit Bharat, MBBS, and colleagues in the Division of Thoracic Surgery and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, spent the past several years honing this highly precise, minimally invasive, lung-conserving, robot-guided outpatient surgery. Now, it is available to all Northwestern Medicine patients with a high-risk lung nodule who are referred with concerns for lung cancer.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has been awarded a five-year, $9.2 million grant renewal from the National Cancer Institute to continue a Specialized Program of Research Excellence (SPORE) in prostate cancer.
A colonoscopy maneuver to better detect polyps in the right colon is often poorly preformed in practice, according to a Northwestern Medicine study.
Lurie Cancer Center nurses, Caroline Mangan, MSN, RN, OCN, and Sarah Miyata, MSN, ACNP-BC, were recognized for their professionalism and exceptional patient care by the Lymphoma Research Foundation (LRF).
Marquita Lewis-Thames, PhD, a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, is partnering with Alan Wan, DO, a medical oncologist at Northwestern Medicine Huntley Hospital, to improve health outcomes for lung cancer survivors in some rural Illinois communities.
Northwestern Medicine investigators have discovered the epigenetic mechanisms involved in the regulation of two oncogenes in glioma cells, which may improve personalized approaches to treat these cancers.
Fluorescent indocarbocyanine lipid labels show improved distribution within glioblastoma brain tumors, according to a Northwestern Medicine study.
Losing a check on T-cell activation in cutaneous T-cell lymphoma cells is associated with poor outcomes, according to a study published in Blood.
Using circulating tumor DNA to identify patients at risk for urothelial cancer relapse after surgical resection could help improve post-surgery treatment, according to a new study.
Enhancing the anti-cancer function of natural killer cells with nanoparticles could unlock their therapeutic potential, according to a Northwestern Medicine study.
See more news in the article archive.